The limitations of traditional cancer treatments are driving the creation and development of
new nanomedicines. At present, with the rapid increase of research on nanomedicine in the …

Aptamers are single-stranded DNA or RNA sequences that can specifically bind with the
target protein or molecule via specific secondary structures. Compared to antibody-drug …

Tumor biomarker‐based theranostics have achieved broad interest and success in recent
years. However, single biomarker‐based recognition can cause false‐positive feedback …

Aptamer-based detection and therapy have made substantial progress with cost control and
easy modification. However, the conformation lability of an aptamer typically causes the …

Due to the limitations of conventional cancer treatment methods, nanomedicine has
appeared as a promising alternative, allowing improved drug targeting and decreased drug …

Drug carriers have gained significant attention in recent years for their ability to enhance the
bioavailability of drugs and minimize adverse effects. However, some carriers, which are …

Cobalt diselenide (CoSe2) hierarchical clew-like structure is synthesized via a dual-
surfactant templated hydrothermal process, and for the first time, its microwave absorption …

Over the past few decades, rapid advances of nucleic acid nanotechnology always drive the
development of nanoassemblies with programmable design, powerful functionality …

As a carrier of genetic information, DNA is a versatile module for fabricating nanostructures
and nanodevices. Functional molecules could be integrated into DNA by precise base …

The development of DNA nanotechnology has attracted tremendous attention in
biotechnological and biomedical fields involving biosensing, bioimaging and disease …